Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

GABA-A receptor ligands disclosed by Synthelabo

Aug. 16, 1996

Marinol potential in Alzheimer's disease patients reported at congress

Aug. 16, 1996

Sandoz announces Exelon pivotal study results

Aug. 16, 1996

NBI-5788 to enter clinical testing for M.S.

Aug. 16, 1996

Myotrophin expanded access program initiated

Aug. 16, 1996

Genetic insights into MS reported

Aug. 16, 1996

Pfizer investigates enantiomeric profiles of citalopram, fluoxetine

Aug. 16, 1996

Lamotrigine, valproate tested in mood disorders

Aug. 16, 1996

Meiji Seika claims bicyclic thiazoles for CNS disorders

Aug. 16, 1996

Allelix describes D4 antagonists for schizophrenia

Aug. 16, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 22, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.